Bionime GM100 series acquires “Innovation Award” from Mediphar Taipei
 8 winners chosen from a pool of 39 candidates!Bionime Rightest GM100 series acquires “Innovation Award” from Mediphar Taipei and becoming the only one winner who targets the field of Self-Monitoring Blood Glucose (SMBG). 39 candidates attended this competition, whereas 15 were selected to participate in the second round. After strict evaluation, 8 products won the award. Besides the Rightest GM100 series, products like XT series, continuous positive airway and A1C express received the award.
The state-of-the art expertise and experience in product design is proven in the entire BIONME product line. Specialists in the field of corporate product design, design innovation and product development, are continuously occupied to improve and develop the product performance and image worldwide. The Mediphar award confirms the initiative and efforts and proves that the latest design elements considered in the development of the GM100 series are fashioned and respond to the market requirements.
BIONIME together with qualified experts in the field of diabetes have initiated and completed also several SMBG patents since 2003 when the company was established. Nevertheless, innovation and creativity will continue to characterize BIONIME’s efforts in the SMBG field.
|
